Notably, KPNA1 and MECP2 exhibited consistent downregulation across both bone marrow and blood samples, indicating a uniform response to AML across different tissues, although opposite to the upregulation observed in benzene-exposed workers. This evidence concerns the gene KPNA1 and acute myeloid leukemia.